When the U.S. government eventually legalizes marijuana, there will undoubtedly be a lot more businesses looking to expand into the growing industry. The current federal ban on pot means that large companies with robust logistical abilities don't generally see the point of getting involved, since marijuana can't cross state lines. But there's hope that with Senate Majority Leader Chuck Schumer leading the charge and pushing for marijuana reform (which includes legalization), significant changes could be coming soon.
WeedLife News Network
Want to know how I know that weed is going to be legalized on a federal level fairly soon Insurers are getting ready. That’s right! One of these days you’ll be able to get weed insurance on your crops, cannabis-related business ventures and much more.
There is no denying that cannabis is BIG business. Some estimates believe that by 2026 the cannabis industry could hit $41b annually. Despite the yearly earnings for the cannabis industry, insurers only wrote out about 250 million in policies and in many cases are charging far more than typical retailers with extreme limits in place.
This might not be of significant importance to consumers, but if insurers do get a chance to play with the cannabis industry, it could revolutionize the industry within a matter of months.
As different as they may seem, there's some overlap between the cannabis industry and biotech that's worth understanding as an investor. Cultivators can use biotechnology to manipulate the genes of marijuana plants to increase their yield, and biotechs can use the bioactive chemicals contained in cannabis as jumping-off points for drug development efforts.
Both of the companies I'll analyze today conduct their business within these overlapping regions. And, if their efforts continue to pan out as planned, they'll be valuable stocks to own, especially as the biotech sector becomes more sophisticated and as the cannabis industry scales to match global demand.
Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-launch of its first-generation medical cannabis inflorescence products.
There is a major debate about the loss of Afghanistan, but for the most part, it has followed the Prime Directive: “Don’t mention the Drug War!”
Nonetheless, it seems relevant that Afghanistan is still the world’s largest opium poppy producer.
According to Reuters, “Despite the threats posed by Afghanistan’s illicit drug business, experts noted, the United States and other nations rarely mention in public the need to address the trade, estimated by the UNODC at more than 80% of global opium and heroin supplies.”
So, we controlled the country? And our Drug War was subsidizing the Taliban?
New York, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The Cannabis Society is pleased to announce that they are hosting a worldwide hybrid conference covering two distinct topics: European Medical Cannabis and North American MSO Growth and Consolidation on Tuesday, September 21st, 2021. This one-day conference will start with discussions surrounding European Medical Cannabis and move into North American MSO Growth and Consolidation in the afternoon.
The Anantara Chiang Mai resort in Thailand has launched ‘healthy and nutrition-rich’ cannabis-infused food and drink at its on-site restaurant. Jenny Southan reports
National retail sales figures for July included a small segment called “miscellaneous store retailers,” in which the U.S. Department of Commerce included the no-longer-so-small cannabis dispensaries.
With sales at the nation's miscellaneous store retailers increasing by 3.5% in July from June to a record $14 billion — at a time when total retail sales lagged — the Wolf Report looked at one state and concluded that the boom was partly driven by cannabis retail sales.
California at the forefront
The report's author, Wolf Richter, used California's cannabis market, currently the world's largest, as an example, and this is what he found out.
Top Marijuana Penny Stocks In August 2021
As the stock market continues higher are you looking for top marijuana stocks to buy? In the first quarter, the best cannabis stocks rallied until February 10th. Since that time the cannabis sector has declined for several months and is now trading near its lowest market value this year. In the first quarter of 2021 one area that saw significant gains is marijuana penny stocks.
A medical cannabis dispensary crowdfunded by residents in southwestern Pennsylvania will open its third location in October.
Maitri Medicinals, the number one craft flower producer in Pennsylvania, will debut a storefront in Greensburg just three years after entering the state’s competitive dispensary market.
Nets star Kevin Durant will be partnering with Weedmaps, an online market that sells marijuana. In the process, Durant wants to prove stereotypes made on marijuana usage in sports wrong. On the Boardroom, CEO Rich Kleiman sat down with the 2X NBA Champion and Weedmaps CEO Chris Beals on this matter. In the discussion, Durant kept things real:
“The band aid has been ripped off. In the sports world, it’s kind of an undercover thing that players use cannabis and used it while they were actively playing. I always thought that was an interesting thing, even as I started coming into the league. You hear the conversation more and more around the league about it.”
Key Points
These multi-state operators are some of the biggest names in the industry and could be solid options for growth investors.While Curaleaf is in the top spot for revenue today, that could change once the Trulieve-Harvest Health merger is complete.Green Thumb Industries and Cresco Labs are also neck-and-neck in revenue and aren't far behind the industry leaders.Canadians looking for exponential gains can consider investing in the cannabis sector. Canada legalized marijuana for recreational use almost three years back, and now it’s quite possible for pot to be legalized at the federal level in the United States as well. However, while Canadian cannabis producers such as Aurora Cannabis (TSX:ACB)(NYSE:ACB) are struggling with lower-than-expected demand, negative profit margins, and a slew of other structural issues, their counterparts south of the border continue to grow at an enviable pace.
The popularity of cannabis is not going anytime soon. In fact, cannabis sales in Canada are already skyrocketing. So, if you like to use cannabis to manage your everyday life and do not want to be stressed all the time, this article is just for you.
Understandably, if you are using cannabis for managing your medical condition, you’ll want to have your medicine stocked at all times. Moreover, you won’t want to pay a lot of money to get access to this as well.
So, if you want to get access to quality cannabis strains without any troubles, consider buying weed in bulk (as long as you stay within your state’s regulations). Don’t find it convincing yet? Here are the reasons why buying cannabis in bulk will be a wise decision for you.
The Native California ladybug voluntarily comes to Autumn Brands, eating all the aphids in their path and helping to produce cannabis crops without the use of insecticide sprays
Cilo Cybin Pharmaceutical Ltd. is considering an initial public offering in the next 12 months after becoming the first South African company to win the right to grow, process and package cannabis products.
The firm, named after the psychoactive substance in magic mushrooms, received the required certification from the South African Health Products Regulatory Authority. It will now be able to produce marijuana for sale to consumers around the world, founder and Chief Executive Officer Gabriel Theron said in an interview.
Schwazze (OTCQX), previously operating as Medicine Man Technologies, revealed Monday it has signed an agreement to acquire the assets of Brow 2, LLC, located in Denver, Colorado for $6.7 million in cash. The planned transaction includes a 37,000 square foot building (27,000 square feet of canopy) for indoor cultivation and equipment. (Article originally appeared on Benzinga by Nina Zdinjak)
This transaction continues Schwazze's aggressive expansion in Colorado and will significantly enhance the Company's cultivation resources, providing product directly to its seventeen Star Buds brand dispensaries.
The acquisition is expected to close in the third quarter of 2021 after the Colorado Marijuana Enforcement Division and local licensing approval.
"Employers cannot control their employees’ private lives by calling the legal use of marijuana outside of work hours ‘misconduct.’"
Michigan residents who consume cannabis may be disqualified from receiving unemployment benefits if employees are shown to have cannabis metabolites in their systems when drug-tested — even if the employee consumed the drug on their personal time, and despite the fact that medical and adult-use cannabis are legal in the state.
SAO PAULO (Reuters) – International cannabis companies are showing interest in Brazil, both its large consumer market for medicinal products and a proposal that could legalize planting of the crop.
Major producers like Colombia’s Clever Leaves and Canada’s Canopy Growth are developing and selling medicinal cannabis products to a Brazilian consumer segment estimated at 10 million to 13 million people. This results from a 2019 regulatory change allowing the import, sale and manufacturing of such products.
But permission for cultivation of hemp and cannabis in Brazil would be a bigger prize. If granted, the industry could blossom in four to five years, based on the experience of other countries such as Colombia.
The straight-laced cousin of cannabis is becoming a mainstream food product, with some impressive nutritional credentials.
Hemp is shaking off its stoner and hippy connotations and gaining a foodie following as more people come to appreciate the plant’s taste and nutritional benefits.
Having garnered widespread acceptance since the Australian Government declared it legal to sell hemp as a food in late 2017, hemp’s protein-rich seed has made its way onto supermarket shelves, and into products ranging from hemp burger patties to nut bars, beer, gin and kombucha.

